CSL price action does not look like it will test support this time & I note UBS's recent repot has a 12-month rating 'Buy' with a 12m price target A$41.20/US$38.40.
Their reasons provided include:
�� BAX contemplates price increases & others rebate? Follow reimbursement
�� And the winners are; BAX & CSL…
�� US channel checks mixed – but not on Gammagard Liquid & Carimune
�� Valuation: PT $41.20ps (includes $2.50 cash); Buy rating (unchanged)
CSL daily chart: Price action currently contained within one of those pointy things - wonder if it will break out this time?
buy in time, and for the future, page-5
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$272.45 |
Change
-4.560(1.65%) |
Mkt cap ! $131.9B | |||
| Open | High | Low | Value | Volume |
| $271.21 | $273.30 | $270.09 | $242.9M | 890.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 99 | $272.45 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $272.68 | 713 | 1 |
View Market Depth
| Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
| CSL (ASX) Chart |